Biotech

Chemotherapy may be completed within 8 days with two doses of Polytaxel, an innovative anticancer drug from South Korea's biotech firm

Polytaxel, a novel pain-free anticancer drug, may not require break periods A new standard of care, more convenient than docetaxel, is suggest...

 November 28, 2022 | News

AstraZeneca Thailand Wins Two ACES Awards 2022

AstraZeneca (Thailand) Co., Ltd., was recently honoured with two accolades in the categories of Industry Champions of the Year and Comm...

 November 25, 2022 | News

Merck Aims to Double R&D Productivity in Oncology, Neurology and Immunology to Deliver more Medicines to Patients Faster

Company aims to launch one new product or indication every 1.5 years on average, bolstered by external innovation Phase III assets xevinapant and evobru...

 November 23, 2022 | News

Merck Confirms Guidance for 2022 and Delivers Strong Organic Growth in Q3

Results of the third quarter of 2022 Group net sales rise by 16.8% to € 5.8 billion Strong organic sales growth of 7.1%, driven by the &...

 November 14, 2022 | News

10x Genomics Launches BEAM to Improve and Streamline Antibody and T-Cell Receptor Discovery

10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health,  announced the commercial ava...

 November 10, 2022 | News

Merck Announces Collaboration with Biotheus to Accelerate Drug Submission and Approval Process for Biopharmaceutical Industry in China

Merck to offer its first-to-market Blazar ® Rodent Panel for virus testing Reduces biosafety turnaround time by up to 80% Reduces animal ...

 November 08, 2022 | News

FUJIFILM Diosynth Biotechnologies enters into an Agreement with Argenx

FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization for biologics, vaccines, and advanced therapies toda...

 October 28, 2022 | News

Merck Showcases Depth of MS Portfolio at ECTRIMS Supporting Commitment to Advancing MS Care

Company’s scientific leadership will be highlighted in 39 abstracts presented across its multiple sclerosis (MS) portfolio Data on investigational...

 October 26, 2022 | News

T-cells treated by Turn Biotechnologies show increased cancer-killing effectiveness

Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today presents interim pre-c...

 October 25, 2022 | News

Sartorius Enters Research Partnership with The BASE Facility at the University of Queensland

Sartorius entered a research partnership with The BASE Facility at The University of Queensland (UQ) to improve the manufacturing process of nucleic a...

 October 24, 2022 | News

Thermo Fisher Scientific Launches Closed and Automated Cell Isolation and Bead Removal Solution to Help Evolve Cell Therapy Manufacturing

Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibco™ CTS™ DynaCellect™ Magnetic Separation ...

 October 21, 2022 | News

Pfizer Presents Scientific Advancements in Infectious Disease Prevention and Treatments

Data demonstrate diversity of vaccine and anti-infective portfolio and cutting-edge scientific approach to battling viral and bacterial infections P...

 October 19, 2022 | News

Merck Announced Its Intention To Further Expand Its Leadership in Science and Technology

“Big 3” expected to generate around 80% of sales growth and > 50% of total sales in 2025 Strategic and targeted investments for annu...

 October 11, 2022 | News

Biotium’s New Laser Diode Gel Illuminator Offers a Superior Alternative to LED and UV-based Illumination

Biotium, a leading supplier and inventor of fluorescent tools for life science research, announces the release of the next-gene...

 October 06, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close